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Abstract
We present a unique case of a 42-year-old
gentleman with newly diagnosed Graves’ dis-
ease  and  isolated  right  ventricular  failure.
Extensive  evaluation  to  include  echocardio-
gram and cardiac catheterization were nega-
tive for significant pulmonary hypertension or
coronary artery disease as potential etiologies.
Hyperthyroid induced vasospasm is a rare but
reported clinical entity that serves to be a clin-
ical and diagnostic dilemma.
Case Report
We report the case of a 42-year old man with
a  history  of  pernicious  anemia  and  Graves’
disease, without any previous cardiac history,
who presented to the emergency department
with  pleuritic  chest  discomfort.  Three  days
before the patient had been diagnosed with
Graves’  disease  manifesting  as  palpitations,
increased night sweats, 20 lb. weight loss over
the  previous  three  months,  chronic
headaches,  and  thyroid  enlargement.  On
admission, the patient was taking propranolol
60mg  twice  daily  with  a  planned  future
radioiodine uptake scan and subsequent abla-
tion on an outpatient basis. Physical examina-
tion was significant only for tachycardia and
an enlarged thyroid. There was no friction rub,
murmurs, or appreciable gallops. Chest X-ray
showed  marked  enlarged  cardiac  silhouette
with  pulmonary  vascular  prominence,  right
pulmonary  artery  with  pulmonary  pruning
indicative of history of pulmonary hyperten-
sion, and hazy opacities suggestive of heart
failure  with  pulmonary  edema  (Figure  1).
Electrocardiogram  showed  evidence  of  right
bundle branch block with no ST segment shifts
(Figure  2).  Three  sets  of  serial  cardiac
enzymes were negative with a TSH level less
than  0.005IU/mL,  Free  T4  =  7.7ng/dL.  The
patient was in thyroid storm (Burch-Wartofsky
score 40) secondary to his recently diagnosed
Graves’  disease  and  treatment  was  started
with methimazole 20 mg daily and prednisone
40mg  daily.  Dosage  of  propranolol  was
increased to 80 mg twice daily.  Further car-
diac evaluation with a transthoracic echocar-
diogram showed normal left ventricular size
and function with an ejection fraction estimat-
ed to be 55-65%. The right ventricle (RV) was
severely dilated and hypokinetic with flatten-
ing of the interventricular septum during dias-
tole consistent with isolated volume overload
(Figure  3).  Pulmonary  artery  peak  systolic
pressure was estimated to be 40 mmHg with a
right atrial pressure of 10 mmHg. There was
no evidence of pericardial effusion. A bubble
study to evaluate intra-cardiac shunt was neg-
ative  for  evidence  of  right-to-left  or  left-to-
right shunt. There was no previous echocar-
diogram available for comparison. On day 2 of
hospitalization  the  patient  developed  tran-
sient ST elevation in the inferior leads with
associated  chest  discomfort  which  differed
from his pleuritic chest pain. Since the patient
was allergic to aspirin, administration of clopi-
dogril was started to cover possible acute coro-
nary syndrome; amlodipine 2.5 mg daily was
started for possible coronary spasm. Troponin
T rose from negative (<0.01 ng/mL) to inde-
terminate (0.03 ng/mL) 12 h after the onset of
symptoms  and  serial  electrocardiograms
(ECG) showed diffuse ST elevations with PR
depression  consistent  with  pericarditis  and
not  ST  elevation  myocardial  infarction.  The
patient  was  then  switched  to  colchicines
0.6mg twice daily. NSAIDs were contraindicat-
ed  given  his  known  history  of  angioedema
related  to  their  administration.  To  complete
evaluation, an ECG gated 64-slice CT was per-
formed to evaluate his coronary anatomy and
rule out pulmonary embolism (PE) as a poten-
tial cause of his right ventricular failure and
pulmonary  hypertension.  This  showed  a
severely enlarged right ventricle, no PE, nor-
mal coronary artery origins and normal coro-
nary  calcium  score.  In  addition,  on  some
images  the  proximal  right  coronary  artery
(RCA)  appeared  to  be  possibly  compressed
against  the  chest  wall  during  the  diastolic
phases (Figure 4). 
The patient was then scheduled for a left
and right heart catheterization with plans to
evaluate further the right coronary artery for
possible compression or spasm and to deter-
mine the severity of the pulmonary hyperten-
sion observed on echocardiography. Coronary
angiography did not show any evidence of RCA
compression or spasm (Figure 5). Right heart
catheterization demonstrated mildly elevated
pulmonary  artery  systolic  pressure  of  43
mmHg  systolic;  mean  27  mmHg.  Pulmonary
capillary wedge pressure was 15. The patient
had normal cardiac output of 7.2 L/min by Fick.
No shunt was identified on screening venous
oxygen  concentration  measurements.  The
patient was discharged on colchicine for acute
pericarditis, as well as amlodipine for possible
coronary spasm. 
The patient’s echocardiogram was consis-
tent more with a picture of volume overload
than with pressure overload, as supported by
the patient’s only mildly elevated pulmonary
pressures on both invasive and non-invasive
measurements.  In  addition,  the  D-shaped
deformity  only  occurred  during  diastole  and
not systole. It was felt that the patient suffered
transient coronary spasm which was the cause
of his chest discomfort and ECG changes with
recurrent  inflammation  resulting  in  acute
pericarditis.  
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Discussion
Coronary vasospasm is an atypical etiology
of myocardial infarction which has only recent-
ly been characterized. While there have been
numerous case reports in the past of patients
presenting with typical signs and symptoms of
myocardial infarction in the absence of angio-
graphic evidence of obstructive coronary artery
disease, it was not until the Coronary Artery
Spasm  in  Patients  With  Acute  Coronary
Syndrome study (CASPAR), published in 2008,
that  the  incidence  of  coronary  artery
vasospasm  was  formally  characterized.1-4 In
this prospective study, patients who presented
with acute coronary syndrome underwent elec-
tive coronary angiography. Those without evi-
dence of a culprit coronary lesion underwent
further testing with intracoronary provocation
with acetylcholine to identify the presence of
possible  coronary  artery  vasospasm.  Of  the
28% of patients found to have no angiographic
evidence of a culprit lesion, almost half tested
positive  for  coronary  artery  vasospasm  by
acetylcholine  provocation.4 Our  institution
does not routinely screen for vasospasm and
our patient, therefore, did not undergo acetyl-
choline provocation. He had already received
amlodipine which likely would have resulted in
a potentially false negative result. 
In  conjunction  with  coronary  artery
vasospasm,  hyperthyroidism  has  also  been
identified as a possible etiology of acute pre-
sentations  of  myocardial  infarction.  There
have  been  previous  case  reports  and  series
establishing a relationship between hyperthy-
roidism  and  reversible  pulmonary  hyperten-
sion with resultant right-sided heart failure.5-8
While several theories have been proposed as
to the pathophysiology behind this association,
only recently has there been evidence to show
the direct effects of thyroid hormone at the
level of the endothelium.9
In  2001  Napoli  et  al. demonstrated  that
endothelium was a vascular target for thyroid
hormone, and in patients who were hyperthy-
roid there was marked endothelial vasodilation
at baseline due to excessive endothelial pro-
duction of nitric oxide. In fact, there was an
overall increase in the vascular reactivity of
the  endothelium  such  that  an  exaggerated
response was seen to nitric oxide and norepi-
nephrine. This abnormal vascular profile was
reversed  once  a  euthyroid  state  was  main-
tained after medical treatment for hyperthy-
roidism.9 In  patients  presenting  with  acute
coronary syndrome in the setting of reversible
ventricular dysfunction and hyperthyroidism,
perhaps  coronary  vasospasm  induced  by  the
direct effects of thyroid hormone at supraphys-
iological levels may be the unidentified culprit
lesions in these cases.
In the case of our patient, his presentation
of acute coronary syndrome could be explained
by his hyperthyroid state with resultant exag-
gerated  endothelial  effects  on  the  coronary
artery vasculature and possible pressure and
volume overload. Given the relative lack of sig-
nificant  obstructive  coronary  artery  disease
and  normal  coronary  origins  on  coronary
angiography, as well as by cardiac CT imaging,
this remains a plausible explanation for his
clinical  presentation.  What  remains  unex-
plained  is  the  relative  absence  of  left  sided
ventricular  dysfunction  despite  his  overall
hyperthyroid state.  
On echocardiographic testing, our patient’s
left ventricular function was preserved with an
ejection fraction of 60-65%, without evidence
of left ventricular hypertrophy, left-sided wall
motion abnormalities, or significant diastolic
dysfunction. In contrast, there was clear evi-
dence  of  pure  right  ventricular  dysfunction
with a severely dilated right ventricle and atri-
um, as well as state of volume overload without
significant  pressure  overload.  As  previously
mentioned,  there  is  a  relationship  between
pulmonary hypertension and hyperthyroidism,
especially in cases of right-sided heart failure.
The  level  of  pulmonary  artery  hypertension
present in this particular patient was mild with
a  mean  pulmonary  catheter  wedge  pressure
calculated to be approximately 15 mm Hg and a
mean pulmonary arterial pressure of 27 mm
Hg. Though not seriously elevated, our finding
is consistent with previously published reports
of thyrotoxicosis induced right ventricular fail-
ure.10 Isolated right ventricular failure has also
been  identified  in  the  absence  of  ACS  in
Figure  1.  Portable  chest  X-ray  showed
engorged  pulmonary  vasculature  and
enlarged cardiac silhouette. 
Figure 2. ECG showing left atrial abnor-
mality, rSR’, and left ventricular hypertro-
phy.
Figure 3. Enlarged right ventricle with D-
shaped septum in diastole as expected in
volume overload state.
Figure 4. Right cartery as visualized on car-
diac CT with possible compression in dias-
tole phase.
Figure  5.  Right  coronary  artery  with  no
evidence of compression in diastole during
invasive angiography and no vasospasm on
engagement.  No  acytelcholine  challenge
was performed.Article
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patients  with  thyrotoxicosis.  It  is  well  docu-
mented that thyroid hormone has direct effects
on the inotropic and chronotropic actions of
the heart. It is felt that in patients with thyro-
toxicosis, right ventricular failure is secondary
pressure  overload  from  induced  pulmonary
hypertension  and  volume  overload  from
increased cardiac output.11 Another proposed
explanation for isolated right ventricular is a
direct toxic effect of the thyroid hormone that
results in a form of stunned myocardium that
primarily affects the right ventricle. However,
in the literature this is somewhat controver-
sial.  Given  the  dynamic  ECG  findings  with
associated chest pain, one has to consider the
effects of the patient’s hyperthyroid state and
the likely coronary vasospasm response with
associated volume and pressure overload as a
multi-factorial etiology for his right-sided car-
diac  dysfunction.  What  makes  this  case  so
unique is the diagnostic dilemma which was
presented. It is far more common to have both
left and right ventricle involvement in hyper-
thyroid  induced  cardiomyopthy.  Also,  the
patient’s  clinical  presentation  of  chest  pain
with detectable troponins further complicated
clinical  management.  The  patient  ultimately
was treated for coronary vasospasm, pericardi-
tis,  and  Grave’s  disease.  When  he  was  dis-
charged he was hemodynamically stable, pain
free, and follow-up thyroid ablation was pro-
grammed. Follow-up transthoracic echocardio-
gram showed near resolution of the right ven-
tricular  dysfunction,  chamber  enlargement,
and unchanged left ventricular ejection frac-
tion of 65%. 
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